Observation of Perioperative Outcomes of Robotic Pancreaticoduodenectomy (NCT04171440) | Clinical Trial Compass
CompletedNot Applicable
Observation of Perioperative Outcomes of Robotic Pancreaticoduodenectomy
United States91 participantsStarted 2020-02-18
Plain-language summary
This is a multi-site prospective, single arm, observational study examining the outcomes of robotic pancreaticoduodenectomy.
Who can participate
Age range
18 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* ≥18 years old
* Symptomatic benign, premalignant, or resectable malignant periampullary and pancreatic tumor requiring resection
* Fit to undergo elective pancreaticoduodenectomy after evaluation by the surgical and anesthesiology teams
* Able to consent to participate in the study
* Appropriate for robotic approach as determined by participating surgeons
Exclusion Criteria:
* Arterial (superior mesenteric artery, celiac axis, hepatic artery) or venous involvement (superior mesenteric vein, portal vein) which meets the definition of borderline or unresectable tumor
* Pregnancy
* BMI \>40 kg/m2
* Patient requires an additional surgical resection during the index operation (such as hepatectomy or colectomy)
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Length of hospital stay
Timeframe: up to 90 days post intervention
Trial details
NCT IDNCT04171440
SponsorSidney Kimmel Comprehensive Cancer Center at Johns Hopkins